Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism

Neuroscience

Volumn 193, Issue , 2011, Pages 310-322

  Bergstrom, B P ^a   Sanberg, S G ^b   Andersson, M ^c   Mithyantha, J ^c   Carroll, F I ^d   Garris, P A ^c  

^a MUSKINGUM COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c ILLINOIS STATE UNIVERSITY   (United States)

^d RTI INTERNATIONAL   (United States)

Author keywords

Compensation; Dopamine; Parkinson's disease; Release; Synthesis; Uptake

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER;

ADAPTATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; IN VIVO STUDY; KINETICS; MALE; NERVE CELL PLASTICITY; NERVE ENDING; NONHUMAN; PARKINSONISM; POTENTIOMETRY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTRIC STIMULATION; ELECTROCHEMISTRY; FUNCTIONAL LATERALITY; HYDRAZINES; MALE; OXIDOPAMINE; PARKINSONIAN DISORDERS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TROPANES;

EID: 80052438292     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.07.029     Document Type: Article

References (54)

1. Abercrombie E.D., Bonatz A.E., Zigmond M.J. Effects of l-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 1990, 525:36-44.
2. Altar C.A., Marien M.R., Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. J Neurochem 1987, 48:390-399.
3. Baur J.E., Kristensen E.W., May L.J., Wiedemann D.J., Wightman R.M. Fast-scan voltammetry of biogenic amines. Anal Chem 1988, 60:1268-1272.
4. Bergstrom B.P., Garris P.A. "Passive stabilization" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J Neurochem 2003, 87:1224-1236.
5. Bergstrom B.P., Schertz K.E., Weirick T., Nafziger B., Takacs S.A., Lopes K.O., Massa K.J., Walker Q.D., Garris P.A. Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism. J Neurosci Methods 2001, 106:15-28.
6. Bezard E., Jaber M., Gonon F., Boireau A., Bloch B., Gross C.E. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse. Eur J Neurosci 2000, 12:2892-2900.
7. Cahill P.S., Walker Q.D., Finnegan J.M., Mickelson G.E., Travis E.R., Wightman R.M. Microelectrodes for the measurement of catecholamines in biological systems. Anal Chem 1996, 68:3180-3186.
8. Carelli R.M., Wightman R.M. Functional microcircuitry in the accumbens underlying drug addiction: insights from real-time signaling during behavior. Curr Opin Neurobiol 2004, 14:763-768.
9. Cragg S.J. Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J Neurosci 2003, 23:4378-4385.
10. Daniel J.A., Galbraith S., Iacovitti L., Abdipranoto A., Vissel B. Functional heterogeneity at dopamine release sites. J Neurosci 2009, 29:14670-14680.
11. Doucet G., Descarries L., Garcia S. Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 1986, 19:427-445.
12. Ekesbo A., Rydin E., Torstenson R., Sydow O., Låengström B., Tedrof J. Dopamine autoreceptor function is lost in advanced Parkinson's disease. Neurology 1999, 52:120-125.
13. Fleckenstein A.E., Pögün S., Carroll F.I., Kuhar M.J. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]. J Pharmacol Exp Ther 1996, 279:200-206.
14. Galvan A., Wichmann T. Pathophysiology of parkinsonism. Clin Neurophysiol 2008, 119:1459-1474.
15. Garris P.A., Walker Q.D., Wightman R.M. Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals. Brain Res 1997, 753:225-234.
16. Grace A.A. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 2000, 31:330-341.
17. Gründemann D., Liebich G., Kiefer N., Köster S., Schömig E. Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 1999, 56:1-10.
18. Herdon H., Strupish J., Nahorski S.R. Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition. Brain Res 1985, 348:309-320.
19. Horn A.S. Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 1990, 34:387-400.
20. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1987, 45:19-34.
21. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci U S A 1998, 95:4029-4034.
22. Jones S.R., Garris P.A., Kilts C.D., Wightman R.M. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J Neurochem 1995, 64:2581-2589.
23. Kita J.M., Parker L.E., Phillips P.E., Garris P.A., Wightman R.M. Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors. J Neurochem 2007, 102:1115-1124.
24. McCallum S.E., Parameswaran N., Perez X.A., Bao S., McIntosh J.M., Grady S.R., Quik M. Compensation in pre-synaptic dopaminergic function following nigrostriatal damage in primates. J Neurochem 2006, 96:960-972.
25. Michael A.C., Ikeda M., Justice J.B.J. Mechanisms contributing to the recovery of striatal releasable dopamine following MFB stimulation. Brain Res 1987, 421:325-335.
26. Montague P.R., McClure S.M., Baldwin P.R., Phillips P.E., Budygin E.A., Stuber G.D., Kilpatrick M.R., Wightman R.M. Dynamic gain control of dopamine delivery in freely moving animals. J Neurosci 2004, 24:1754-1759.
27. Near J.A., Bigelow J.C., Wightman R.M. Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. J Pharmacol Exp Ther 1988, 245:921-927.
28. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, New York.
29. Perez X.A., Parameswaran N., Huang L.Z., O'Leary K.T., Quik M. Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates. J Neurochem 2008, 105:1861-1872.
30. Phillips P.E., Hancock P.J., Stamford J.A. Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 2002, 44:15-22.
31. Richard M.G., Bennett J.P. NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions. J Neurochem 1995, 64:2080-2086.
32. Richards D.A., Guatimosim C., Rizzoli S.O., Betz W.J. Synaptic vesicle pools at the frog neuromuscular junction. Neuron 2003, 39:529-541.
33. Rizzoli S.O., Betz W.J. Synaptic vesicle pools. Nat Rev Neurosci 2005, 6:57-69.
34. Robinson T.E., Mocsary M., Camp D.M., Whishaw I.Q. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci 1994, 14:2687-2696.
35. Rothblat D.S., Schneider J.S. Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study. J Neurochem 1999, 72:724-733.
36. Russ H., Staust K., Martel F., Gliese M., Schomig E. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 1996, 8:1256-1264.
37. Schneider J.S. Preservation of autoreceptor-mediated increases in dopamine synthesis in aged mice with experimentally-induced parkinsonism. Neurosci Lett 1997, 222:138-140.
38. Schneider J.S., Rothblat D.S., Distefano L. Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Brain Res 1994, 643:86-91.
39. Schultz W. Behavioral dopamine signals. Trends Neurosci 2007, 30:203-210.
40. Snyder G.L., Keller R.W., Zigmond M.J. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J Pharmacol Exp Ther 1990, 253:867-876.
41. Stachowiak M.K., Keller R.W., Stricker E.M., Zigmond M.J. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. J Neurosci 1987, 7:1648-1654.
42. van Horne C., Hoffer B.J., Strömberg I., Gerhardt G.A. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J Pharmacol Exp Ther 1992, 263:1285-1292.
43. Venton B.J., Seipel A.T., Phillips P.E., Wetsel W.C., Gitler D., Greengard P., Augustine G.J., Wightman R.M. Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 2006, 26:3206-3209.
44. Wiedemann D.J., Kawagoe K.T., Kennedy R.T., Ciolkowski E.L., Wightman R.M. Strategies for low detection limit measurements with cyclic voltammetry. Anal Chem 1991, 63:2965-2970.
45. Wightman R.M., Amatore C., Engstrom R.C., Hale P.D., Kristensen E.W., Kuhr W.G., May L.J. Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 1988, 25:513-523.
46. Wolf M.E., Zigmond M.J., Kapatos G. Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study. J Neurochem 1989, 53:879-885.
47. Wu Q., Reith M.E., Kuhar M.J., Carroll F.I., Garris P.A. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci 2001, 21:6338-6347.
48. Wu Q., Reith M.E., Walker Q.D., Kuhn C.M., Carroll F.I., Garris P.A. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J Neurosci 2002, 22:6272-6281.
49. Wu Q., Reith M.E., Wightman R.M., Kawagoe K.T., Garris P.A. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J Neurosci Methods 2001, 112:119-133.
50. Yavich L., MacDonald E. Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting. Brain Res 2000, 870:73-79.
51. Yavich L. Two simultaneously working storage pools of dopamine in mouse caudate and nucleus accumbens. Br J Pharmacol 1996, 119:869-876.
52. Zigmond M.J. Do compensatory processes underlie the preclinical phase of neurodegenerative disease?. Insights from an animal model of parkinsonism. Neurobiol Dis 1997, 4:247-253.
53. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 1990, 13:290-296.
54. Zigmond M.J., Acheson A.L., Stachowiak M.K., Stricker E.M. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch Neurol 1984, 41:856-861.